Eldelumab (BMS-936557) is a humanized anti-IP-10 IgG type 1 monoclonal antibody with inhibitory activity against CXCL10.Eldelumab has anti-inflammatory activity and selectively binds to CXCL10 and can be used in the study of rheumatoid arthritis, ulcerat
CAS Number:
[946414-98-8]
Target:
CXCR
* VAT and and shipping costs not included. Errors and price changes excepted